z-logo
open-access-imgOpen Access
WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
Author(s) -
Christine Lainé,
Kyu Sang Joeng,
Philippe M. Campeau,
Riku Kiviranta,
Kati Tarkkonen,
Monica Grover,
James T. Lu,
Minna Pekkinen,
Maija Wessman,
Terhi J. Heino,
Vappu Nieminen-Pihala,
Mira Aronen,
Tero Laine,
Heikki Kröger,
William G. Cole,
AnnaElina Lehesjoki,
Lisette Nevarez,
Deborah Krakow,
Cynthia J. Curry,
Daniel H. Cohn,
Richard A. Gibbs,
Brendan Lee,
Outi Mäkitie
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1215458
Subject(s) - osteogenesis imperfecta , missense mutation , wnt signaling pathway , nonsense mutation , mutation , osteoporosis , genetics , medicine , lineage (genetic) , biology , gene , pathology
This report identifies human skeletal diseases associated with mutations in WNT1. In 10 family members with dominantly inherited, early-onset osteoporosis, we identified a heterozygous missense mutation in WNT1, c.652T→G (p.Cys218Gly). In a separate family with 2 siblings affected by recessive osteogenesis imperfecta, we identified a homozygous nonsense mutation, c.884C→A, p.Ser295*. In vitro, aberrant forms of the WNT1 protein showed impaired capacity to induce canonical WNT signaling, their target genes, and mineralization. In mice, Wnt1 was clearly expressed in bone marrow, especially in B-cell lineage and hematopoietic progenitors; lineage tracing identified the expression of the gene in a subset of osteocytes, suggesting the presence of altered cross-talk in WNT signaling between the hematopoietic and osteoblastic lineage cells in these diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom